Prevalence and Incidence of Neuronal intranuclear inclusion disease

Neuronal intranuclear inclusion disease: Rare Disease

Neuronal intranuclear inclusion disease is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Neuronal intranuclear inclusion disease, or a subtype of Neuronal intranuclear inclusion disease, affects less than 200,000 people in the US population.

Ophanet, who are a consortium of European partners, currently defines a condition rare when if affects 1 person per 2,000. They list Neuronal intranuclear inclusion disease as a "rare disease". More information about Neuronal intranuclear inclusion disease is available from Orphanet

About prevalence and incidence statistics:

The term 'prevalence' of Neuronal intranuclear inclusion disease usually refers to the estimated population of people who are managing Neuronal intranuclear inclusion disease at any given time. The term 'incidence' of Neuronal intranuclear inclusion disease refers to the annual diagnosis rate, or the number of new cases of Neuronal intranuclear inclusion disease diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

Search Specialists by State and City